{
    "pmcid": "9688389",
    "qa_pairs": {
        "What is a challenge associated with using nanobodies in biosensing applications?": [
            "Oriented immobilization on transducers to maintain binding efficiency.",
            "Limited availability of camelid antibodies for nanobody production.",
            "High immunogenicity leading to potential allergic reactions.",
            "Difficulty in achieving high specificity for viral targets."
        ],
        "What is a key advantage of nanobodies over traditional antibodies in SARS-CoV-2 detection?": [
            "Nanobodies can access antigenic sites inaccessible to larger antibodies.",
            "Nanobodies are less expensive to produce than traditional antibodies.",
            "Nanobodies have a longer half-life in the bloodstream than traditional antibodies.",
            "Nanobodies can be easily administered orally compared to traditional antibodies."
        ],
        "What is the primary focus of using ACE2 in the context of SARS-CoV-2 detection?": [
            "To develop rapid, cost-effective, and reliable diagnostic tools for point of care use.",
            "To create a vaccine that targets the ACE2 receptor to prevent infection.",
            "To engineer ACE2 to act as a therapeutic agent against SARS-CoV-2.",
            "To study the genetic variations of ACE2 in different populations."
        ],
        "What potential broader application is suggested for nanobodies beyond SARS-CoV-2 detection?": [
            "Developing biosensors for other emerging viral threats.",
            "Creating universal vaccines for all coronaviruses.",
            "Engineering nanobodies to act as antiviral drugs.",
            "Using nanobodies in gene therapy for viral infections."
        ],
        "Which biosensing platforms have nanobodies been integrated into for detecting SARS-CoV-2?": [
            "Field-effect transistor (FET) and differential pulse voltammetry (DPV) based systems.",
            "Enzyme-linked immunosorbent assay (ELISA) and lateral flow assay systems.",
            "Mass spectrometry and nuclear magnetic resonance (NMR) based systems.",
            "Fluorescence resonance energy transfer (FRET) and bioluminescence systems."
        ]
    }
}